Smittenaar, Peter
Walker, Alexandra K.
McGill, Shaun
Kartsonaki, Christiana
Robinson-Vyas, Rupesh J.
McQuillan, Janette P.
Christie, Sarah
Harris, Leslie
Lawson, Jonathan
Henderson, Elizabeth
Howat, Will
Hanby, Andrew
Thomas, Gareth J.
Bhattarai, Selina
Browning, Lisa
Kiltie, Anne E. http://orcid.org/0000-0001-7208-2912
Article History
Received: 26 January 2018
Revised: 18 May 2018
Accepted: 31 May 2018
First Online: 11 July 2018
Competing interests
: The authors declare no competing interests.
: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
: Ethical approval was obtained from London Bromley NRES (study 13/LO/0540), Leeds (East) Local Ethical Committee (studies 02/060 and 04/Q1206/62) and North West–Haydock Research Ethics Committee (study 14/NW/1033). Patients whose samples were collected from 2002 onwards gave informed consent for use of their pre-treatment biopsies. The study was performed in accordance with the Declaration of Helsinki.
: We acknowledge funding from Cancer Research UK, Cancer Research UK programme grant C5255/A15935 (AEK) and the research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) (Molecular Diagnostics Theme/Multimodal Pathology Subtheme) (L.B.). A.W. was funded by an MRC studentship (MR/K501256/1).